Services > Immune-Oncology

Immune Cell Repertoire Sequencing

Diversity of adaptive immune response is key biomarker for monitoring immune response.

Using Next Generation Sequencing (NGS), we have developed a quantitative unbiased technology allowing to monitor T-cell clonotypes (TCRseq) and diversity assessment on blood or solid tissue biological samples.

Main applications:

  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases

Doctors and scientists can help you.

©   Seqalis™, a company trademark - All rights reserved. Design by Oblique.